A detailed history of Jackson Hole Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 1,306 shares of LLY stock, worth $1.18 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,306
Previous 1,306 -0.0%
Holding current value
$1.18 Million
Previous $761,000 33.51%
% of portfolio
0.23%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $1,304 - $1,797
3 Added 0.23%
1,306 $701,000
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $16,835 - $22,511
-48 Reduced 3.55%
1,303 $611,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $1,242 - $1,459
4 Added 0.3%
1,351 $463,000
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $964 - $1,124
3 Added 0.22%
1,347 $492,000
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $398,469 - $454,097
1,344 New
1,344 $435,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jackson Hole Capital Partners, LLC Portfolio

Follow Jackson Hole Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.